Search results for "Acute [MeSH]"

showing 10 items of 350 documents

Repurposing of the ALK inhibitor crizotinib for acute leukemia and multiple myeloma cells

2021

Crizotinib was a first generation of ALK tyrosine kinase inhibitor approved for the treatment of ALK-positive non-small-cell lung carcinoma (NSCLC) patients. COMPARE and cluster analyses of transcriptomic data of the NCI cell line panel indicated that genes with different cellular functions regulated the sensitivity or resistance of cancer cells to crizotinib. Transcription factor binding motif analyses in gene promoters divulged two transcription factors possibly regulating the expression of these genes, i.e., RXRA and GATA1, which are important for leukemia and erythroid development, respectively. COMPARE analyses also implied that cell lines of various cancer types displayed varying degr…

medicine.drug_classPharmaceutical Scienceacute myeloid leukemiaArticletranscriptomicsPharmacy and materia medicaDrug Discoverytyrosine kinase inhibitorsmedicineCytotoxic T cellnetwork pharmacologyddc:610biologyCrizotinibdrug repurposingChemistryTopoisomeraseRMyeloid leukemiaCell cyclemedicine.diseaseALK inhibitorRS1-441multiple myelomaLeukemiaCancer cellbiology.proteinCancer researchMolecular MedicineMedicinemedicine.drug
researchProduct

Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study

2021

AIMS: Although acute heart failure (AHF) with volume overload is treated with loop diuretics, their dosing and type of administration are mainly based upon expert opinion. A recent position paper from the Heart Failure Association (HFA) proposed a step-wise pharmacologic diuretic strategy to increase the diuretic response and to achieve rapid decongestion. However, no study has evaluated this protocol prospectively. METHODS AND RESULTS: The Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure (ENACT-HF) study is an international, multicentre, non-randomized, open-label, pragmatic study in AHF patients on chronic loop diuretic therapy, admitted to the hospital for intravenous …

medicine.drug_classmedicine.medical_treatmentStudy DesignsDecongestionVolume overloadDiuresisNatriuresisSodium Potassium Chloride Symporter InhibitorsFurosemideAcute heart failure; Diuretics; Urinary sodium; Decongestion; ProtocolmedicineClinical endpointProtocolHumansDiseases of the circulatory (Cardiovascular) systemInfusions IntravenousDiureticsHeart FailureUrinary sodiumStudy Designbusiness.industryFurosemideAcute heart failureLoop diureticmedicine.diseaseAnesthesiaHeart failureRC666-701DiureticCardiology and Cardiovascular Medicinebusinessmedicine.drugESC Heart Failure
researchProduct

Comparison of frequency domain measures based on spectral decomposition for spontaneous baroreflex sensitivity assessment after Acute Myocardial Infa…

2021

Abstract The objective of this study is to present a new method to assess in the frequency domain the directed interactions between the spontaneous variability of systolic arterial pressure (SAP) and heart period (HP) from their linear model representation, and to apply it for studying the baroreflex control of arterial pressure in healthy physiological states and after acute myocardial infarction (AMI). The method is based on pole decomposition of the model transfer function and on the following evaluation of causal measures of coupling and gain from the poles associated to low frequency (0.04−0.15 Hz) oscillatory components. It is compared with traditional non-causal approaches for the sp…

medicine.medical_specialty0206 medical engineeringBiomedical EngineeringHealth Informatics02 engineering and technologyAcute myocardial infarctionBaroreflexSettore ING-INF/01 - ElettronicaMatrix decomposition03 medical and health sciences0302 clinical medicineInternal medicinemedicineSpectral analysiscardiovascular diseasesMyocardial infarctionSensitivity (control systems)Spectral decompositionbusiness.industryHead-up tiltLinear modelBaroreflexmedicine.disease020601 biomedical engineeringFrequency domainCausalityBlood pressureFrequency domainCardiovascular controlSignal ProcessingSettore ING-INF/06 - Bioingegneria Elettronica E InformaticaCardiologybusiness030217 neurology & neurosurgery
researchProduct

Assessment of no-reflow phenomenon by myocardial blush grade and pulsed wave tissue doppler imaging in patients with acute coronary syndrome

2014

Background: No-reflow phenomenon is a complication of myocardial revascularization and it is associated with a worse prognosis. Materials and Methods: A prospective study was carried out enrolling patients with acute myocardial infarction (64 patients, 49 male and 15 female, median age 64.9 ± 10.61 years), both STEMI and NSTEMI, who underwent myocardial revascularization with percutaneous coronary intervention (PCI). TIMI flow and Myocardial Blush Grade (MBG) were assessed at baseline (T0), in addition to tissue Doppler imaging (TDI) and electrocardiogram. Cardiological evaluation was also performed at T1 (one month after PCI) and T2 (every year after revascularization for a mean follow-up …

medicine.medical_specialtyAcute coronary syndromemyocardial blush gradebusiness.industrymedicine.medical_treatmentDiastolePercutaneous coronary interventionAcute myocardial infarctionRevascularizationmedicine.diseaseInternal medicineConventional PCINo reflow phenomenonCardiologymedicineOriginal ArticleRadiology Nuclear Medicine and imagingMyocardial infarctionno reflowCardiology and Cardiovascular Medicinebusinessmyocardial perfusiontissue doppler imagingTIMIJournal of Cardiovascular Echography
researchProduct

Why, whether and how to use high-flow nasal therapy in acute exacerbations of chronic obstructive pulmonary disease

2021

Noninvasive ventilation (NIV) represents the standard of care for respiratory support of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) developing acute hypercapnic respiratory failure (AHRF) [1]. NIV has been shown to reduce patient’s work of breathing and mortality and be feasibly implemented in various hospital location facilities at different timing, based on the severity of AHRF [2] and it is also widely used in clinical practice by physicians [3]. However, clinicians’ knowledge, experience and expertise in the management of NIV are crucial for its success in order to overcome common problems that may lower its effectiveness such as patients’ discomf…

medicine.medical_specialtyAcute hypercapnic respiratory failureacute respiratory failurehigh-flow nasal cannulabusiness.industryHealth PolicyPulmonary diseasenoninvasive ventilationPulmonary Disease Chronic ObstructiveCOPD exacerbationCopd exacerbationInternal medicineCardiologymedicineHumansNoninvasive ventilationAcute respiratory failureHigh flowbusinessNIV HFNTacute hypercapnic respiratory failure
researchProduct

Cardiorenal syndrome followed by acute hepatitis C in a patient with acute myeloid leukemia

1969

SUMMARY Cardiorenal syndrome involves altering cardiac and renal function. These patients frequently develop resistance to diuretic therapy, so that ultrafiltration should be applied in emergency for saving them. Concomitant presence of an active hematologic malignancy represents an important complicating factor. We present the case of an elderly patient with acute myeloid leukemia, appeared on the background of myelodysplastic syndrome who, during marrow aplasia occurred after the first course of induction chemotherapy, developed a cardiorenal syndrome, which required repeated sessions of hemodialysis. Complete hematologic remission and efficiency of fluid depletion therapy allowed the sec…

medicine.medical_specialtyAcute leukemiaAcute leukemiabusiness.industrymedicine.medical_treatmentCardiorenal syndromeMyeloid leukemiaRenal functionInduction chemotherapyCase ReportGeneral MedicineCardiorenal syndromeAplasiamedicine.diseaseGastroenterologyCholesterolInternal medicineConcomitantHemodialysismedicineHemodialysisAcute hepatitisIntensive care medicinebusinessPakistan Journal of Medical Sciences
researchProduct

Management of Blood Pressure and Heart Rate in Patients with Acute Stroke

2017

BACKGROUND: Stroke represent one of the most devastating of all neurological diseases, affecting about 15 million people per year and is an important cause of morbidity and mortality worldwide and currently the leading cause of adult disability in developed countries. Blood pressure and heart rate may undergo several modifications in patients with both ischemic and hemorrhagic stroke in fact raised blood pressure levels may lead to cerebral edema, hematoma expansion or hemorrhagic transformation and in contrast low blood pressure can lead to increased cerebral infarction or perihematomal ischemia. In addition, ECG abnormalities and cardiac arrhythmias, especially atrial fibrillation, are re…

medicine.medical_specialtyAdrenergic beta-AntagonistsIschemiaInfarctionBlood Pressureheart rate monitoringSudden death03 medical and health sciences0302 clinical medicineHeart RateInternal medicineDrug DiscoverymedicineHumansAcute strokehemorrhagic strokecardiovascular diseasesDiureticsStrokePharmacologyCerebral infarctionbusiness.industrymiocardial infarctionAtrial fibrillationmedicine.diseaseStrokeblood pressure modulationBlood pressure030220 oncology & carcinogenesisHeart failureAcute Diseaseperihematomal ischemiaCardiologybusiness030217 neurology & neurosurgeryCurrent Pharmaceutical Design
researchProduct

Is acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHF

2020

Aims: \ud This retrospective analysis sought to identify markers that might distinguish between acute heart failure (HF) and worsening HF in chronic outpatients.\ud \ud Methods and Results: \ud The BIOSTAT‐CHF index cohort included 2516 patients with new or worsening HF symptoms: 1694 enrolled as inpatients (acute HF) and 822 as outpatients (worsening HF in chronic outpatients). A validation cohort included 935 inpatients and 803 outpatients. Multivariable models were developed in the index cohort using clinical characteristics, routine laboratory values, and proteomics data to examine which factors predict adverse outcomes in both conditions and to determine which factors differ between ac…

medicine.medical_specialtyAdverse outcomesacute heart failure treatment030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemacute heart failure diagnosisInternal medicineOutpatientsDiagnosismedicineRetrospective analysisHumansAcute heart failure; acute heart failure diagnosis; acute heart failure treatmentRetrospective StudiesHeart Failurebusiness.industryTreatment developmentRoutine laboratoryAcute heart failurePrognosismedicine.diseaseR1[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemHospitalizationTreatmentHeart failureChronic DiseaseCohortBiomarker (medicine)Cardiology and Cardiovascular MedicinebusinessCarbohydrate antigen
researchProduct

AGE DIFFERENCES IN THE ACUTE STRESS EFFECTS ON DECLARATIVE MEMORY PERFORMANCE

2021

"In the last decades, there has been a growing interest in knowing the effects of acute stress on memory performance, particularly declarative memory. Research on this topic suggests that age is a crucial individual factor to consider in the stress-memory link. However, most of the evidence has been obtained from studies conducted in young people and, surprisingly, studies in older people are scarce. Thus, our aim was to investigate the age differences in the acute stress effects on declarative memory performance. To do this, we directly compared the effects of a psychosocial acute stressor (i.e. Trier Social Stress Test) on learning, consolidation and memory retrieval performance in two ag…

medicine.medical_specialtyAge differencesbusiness.industryMedicineAcute stressAudiologybusinessDeclarative memoryPsychological Applications and Trends 2021
researchProduct

New insights into symptomatic or silent atrial fibrillation complicating acute myocardial infarction

2015

International audience; Atrial fibrillation (AF) is the most frequent heart rhythm disorder in the general population and contributes not only to a major deterioration in quality of life but also to an increase in cardiovascular morbimortality. The onset of AF in the acute phase of myocardial infarction (MI) is a major event that can jeopardize the prognosis of patients in the short-, medium- and long-term, and is a powerful predictor of a poor prognosis after MI. The suspected mechanism underlying the excess mortality is the drop in coronary flow linked to the acceleration and arrhythmic nature of the left ventricular contractions, which reduce the left ventricular ejection fraction. The p…

medicine.medical_specialtyAsymmetric dimethylarginineSurveillance ECG en continueAsymétrique diméthylargininePopulationMyocardial InfarctionInfarctus du myocardeAcute myocardial infarctionSudden deathContinuous ECG monitoringVentricular Function Left[SHS]Humanities and Social SciencesHeart RateRisk FactorsInternal medicineCoronary CirculationHeart rateAtrial FibrillationmedicinePronosticHumansMyocardial infarctionHospital MortalityeducationHeart FailureFibrillation atriale silencieuseeducation.field_of_studyEjection fractionbusiness.industryAtrial fibrillationStroke VolumeGeneral MedicineStroke volumemedicine.diseasePrognosisMyocardial ContractionOxidative StressSilent atrial fibrillationHeart failureAsymptomatic DiseasesCardiologyEndothelium Vascular[SHS] Humanities and Social SciencesbusinessCardiology and Cardiovascular Medicine
researchProduct